Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | HTR1D | P28221 | 5/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | AGBL2 | Q5U5Z8 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | NOS3 | P29474 | 2/20 | 0.31 |
| ▸ | NOS1 | P29475 | 2/20 | 0.31 |
| ▸ | NOS2 | P35228 | 2/20 | 0.31 |
| ▸ | HTR1A | P08908 | 2/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20047626 | 0.84 | POLB (0.37) | POLBHTR1DTSHRGABRA1GABRB2 | |
| SCHEMBL19117728 | 0.84 | AGBL2 (0.40) | POLBHTR1DTSHRGABRA1GABRB2 | |
| SCHEMBL20457092 | 0.84 | AGBL2 (0.47) | POLBKDM4EAGBL2TDP1LMNA | |
| SCHEMBL13253377 | 0.81 | HSP90AA1 (0.36) | GABRA1GABRB2KDM4EALDH1A1ALOX15 | |
| SCHEMBL12169342 | 0.80 | NOS3 (0.50) | POLBKDM4ENOS3NOS1NOS2 | |
| SCHEMBL12570327 | 0.80 | POLB (0.41) | POLBHTR1DTSHRGABRA1GABRB2 | |
| SCHEMBL24127226 | 0.79 | GAA (0.41) | POLBGABRA1GABRB2KDM4ETP53 | |
| SCHEMBL25569089 | 0.79 | GABRA1 (0.34) | GABRA1GABRB2 | |
| SCHEMBL19504326 | 0.79 | ALOX5AP (0.40) | GABRA1GABRB2 | |
| SCHEMBL18417644 | 0.79 | ALDH1A1 (0.34) | POLBKDM4ELMNAMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0669932-A4 | 17-ALPHA AND 17-BETA SUBSTITUTED ACYL-3-CARBOXY-3,5-DIENES AND USE IN INHIBITING 5-ALPHA-REDUCTASE. | SMITHKLINE BEECHAM CORP (US) | 1995-10-25 | — | — | EP | claimed |
| EP-0673251-A4 | — | — | 1995-10-25 | — | — | EP | claimed |
| EP-0651643-A4 | 17-ALKYLKETONE STEROIDS USEFUL AS 5--g(a)-REDUCTASE INHIBITORS. | SMITHKLINE BEECHAM CORP (US) | 1995-10-04 | — | — | EP | claimed |
| EP-0638090-A4 | 17-g(a) AND 17-g(b)-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID. | SMITHKLINE BEECHAM CORP (US) | 1995-10-04 | — | — | EP | claimed |
| EP-0673251-A1 | 17 SUBSTITUTED ACYL-3-CARBOXY 3,5-DIENE STEROIDALS AS 5-ALPHA-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0669932-A1 | 17-ALPHA AND 17-BETA SUBSTITUTED ACYL-3-CARBOXY-3,5-DIENES AND USE IN INHIBITING 5-ALPHA-REDUCTASE | SMITHKLINE BEECHAM CORPORATION (US) | 1995-09-06 | — | — | EP | claimed |
| EP-0651643-A1 | 17-ALKYLKETONE STEROIDS USEFUL AS 5-$g(a)-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-05-10 | — | — | EP | claimed |
| US-5399771-A | Process of synthesizing binaphthyl derivatives | MERCK & CO., INC. (US) | 1995-03-21 | — | — | US | claimed |
| EP-0638090-A1 | 17$g(a) AND 17$g(b)-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID | SMITHKLINE BEECHAM CORPORATION (US) | 1995-02-15 | — | — | EP | claimed |
| WO-1994011004-A1 | 17 SUBSTITUTED ACYL-3-CARBOXY 3,5-DIENE STEROIDALS AS 5-ALPHA-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-05-26 | — | — | WO | claimed |
| WO-1994011386-A1 | 17-ALPHA AND 17-BETA SUBSTITUTED ACYL-3-CARBOXY-3,5-DIENES AND USE IN INHIBITING 5-ALPHA-REDUCTASE | SMITHKLINE BEECHAM CORPORATION (US) | 1994-05-26 | — | — | WO | claimed |
| WO-1994000125-A1 | 17-ALKYLKETONE STEROIDS USEFUL AS 5-α-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-01-06 | — | — | WO | claimed |
| WO-1993022333-A1 | 17α AND 17β-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID | SMITHKLINE BEECHAM CORPORATION (US) | 1993-11-11 | — | — | WO | claimed |
| US-20230373960-A1 | INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS | BEONE MEDICINES I GMBH (CH) | 2023-11-23 | — | — | US | disclosed |
| US-20230373960-A1 | INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS | BEONE MEDICINES I GMBH (CH) | 2023-11-23 | — | — | US | disclosed |
| US-20230337517-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| EP-0638090-A1 | 17$g(a) AND 17$g(b)-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID | SMITHKLINE BEECHAM CORPORATION (US) | 1995-02-15 | — | — | EP | disclosed |
| CN-1095382-A | The new A of cyanines family ring steroide | SMITHKLINE BEECHAM CORP (US) | 1994-11-23 | — | — | CN | disclosed |
| WO-1994000125-A1 | 17-ALKYLKETONE STEROIDS USEFUL AS 5-α-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-01-06 | — | — | WO | disclosed |
| WO-1993022333-A1 | 17α AND 17β-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID | SMITHKLINE BEECHAM CORPORATION (US) | 1993-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230373960-A1 | INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS | EGFR, ERBB2, ERBB4 | POLB 2666/4885HTR1D 411/4885TSHR 1241/4885 |
| US-20230337517-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OCIAD2, OCIAD1 | POLB 1363/4885HTR1D 1371/4885TSHR 1214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.